We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
+$2.38M
Cap. Flow %
0.66%
Top 10 Hldgs %
7.17%
Holding
495
New
34
Increased
285
Reduced
131
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.11M
2
HSY icon
Hershey
HSY
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$2.13M
2
TKO icon
TKO Group
TKO
+$2.13M
3
WAT icon
Waters Corp
WAT
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPLX icon
426
MPLX
MPLX
$58.4B
$183K 0.05%
3,210
+185
+6% +$10.5K
HESM icon
427
Hess Midstream
HESM
$5.2B
$182K 0.05%
4,695
-76
-2% -$2.82K
APLE icon
428
Apple Hospitality REIT
APLE
$3.92B
$182K 0.05%
15,836
+2,464
+18% +$29.8K
ITRN icon
429
Ituran Location and Control
ITRN
$1.09B
$181K 0.05%
3,698
-37
-1% -$1.74K
RIGL icon
430
Rigel Pharmaceuticals
RIGL
$681M
$181K 0.05%
6,686
+162
+2% +$5.44K
DMC
431
Del Monte Corp
DMC
$1.35B
$181K 0.05%
4,487
-21
-0.5% -$837
REXR icon
432
Rexford Industrial Realty
REXR
$8.12B
$178K 0.05%
5,442
+1,413
+35% +$53K
SLNO
433
DELISTED
Soleno Therapeutics
SLNO
$176K 0.05%
5,243
+127
+2% +$4.98K
REFI
434
Chicago Atlantic Real Estate Finance
REFI
$256M
$172K 0.05%
15,185
+2,600
+21% +$31.7K
BCYC
435
Bicycle Therapeutics
BCYC
$290M
$170K 0.05%
36,601
+892
+2% +$5.1K
VRDN icon
436
Viridian Therapeutics
VRDN
$2.13B
$165K 0.05%
8,439
+206
+3% +$6.12K
RGNX icon
437
Regenxbio
RGNX
$656M
$165K 0.05%
19,660
+479
+2% +$5.03K
FULC icon
438
Fulcrum Therapeutics
FULC
$251M
$161K 0.04%
20,974
+511
+2% +$4.74K
LXEO icon
439
Lexeo Therapeutics
LXEO
$370M
$160K 0.04%
27,910
+680
+2% +$4.82K
ALT icon
440
Altimmune
ALT
$552M
$159K 0.04%
51,743
+1,261
+2% +$5.35K
IVVD icon
441
Invivyd
IVVD
$179M
$153K 0.04%
117,537
+2,869
+3% +$5.27K
SANA icon
442
Sana Biotechnology
SANA
$893M
$153K 0.04%
53,052
+1,296
+3% +$5.11K
VSTM icon
443
Verastem
VSTM
$543M
$150K 0.04%
28,374
+692
+2% +$4.27K
KROS icon
444
Keros Therapeutics
KROS
$201M
$140K 0.04%
12,676
+309
+2% +$4.77K
ZBIO
445
Zenas BioPharma
ZBIO
$1.96B
$131K 0.04%
6,717
+163
+2% +$3.66K
OLMA icon
446
Olema Pharmaceuticals
OLMA
$1.03B
$123K 0.03%
8,250
+201
+2% +$4.47K
WVE icon
447
Wave Life Sciences
WVE
$1.11B
$119K 0.03%
16,465
+401
+2% +$5.22K
UPB
448
Upstream Bio Inc
UPB
$348M
$90.4K 0.02%
10,046
+245
+2% +$4.41K
MREO
449
Mereo BioPharma
MREO
$46.4M
$41.5K 0.01%
125,662
+3,067
+3% +$1.32K
GOSS icon
450
Gossamer Bio
GOSS
$69.7M
$24.9K 0.01%
75,746
+1,850
+3% +$2.91K
16 17
18
19 20

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return

Virtus Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Virtus Investment Advisers held 495 positions worth $363M, down 1.5% from $368M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Virtus Investment Advisers's Q1 2026 filing shows 34 new, 285 increased, 131 reduced and 45 closed positions. Its largest new stake was Hershey: 9,903 shares worth $2.06M. The largest sale was Huntington Bancshares, an estimated $2.13M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

  • Virtus Investment Advisers's largest Q1 2026 buy was Hershey: 9,903 shares worth $2.06M.
  • Virtus Investment Advisers added most to Amgen in Q1 2026, an estimated $2.11M increase.
  • Virtus Investment Advisers's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $1.56M.
  • Virtus Investment Advisers fully exited Huntington Bancshares in Q1 2026, selling an estimated $2.13M.
  • Virtus Investment Advisers's ten largest holdings make up 7.2% of its $363M portfolio in Q1 2026.
  • Virtus Investment Advisers opened 34 new positions and closed 45 in Q1 2026.
  • Virtus Investment Advisers's portfolio value fell 1.5% quarter-over-quarter to $363M.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.